ConsiGma®

ConsiGma® Direct Compression with Linear Blending (DC-LB) Lines

A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.

Pharma Technology Compression

Continuous Direct Compression

ConsiGma® DC-LB Lines integrate continuous dry blending using linear blenders and tablet compression into one efficient continuous production system.

Available in 2 standard sizes, depending on the desired throughput (from 1 to 100 kg/h or 20,000 to 150,000 tablets/h to be verified by testing), the systems can be customized with a number of options to suit customer needs.

The Conductor 4.0 software ensures seamless control of the entire process and provides full reporting and track & trace.

Mainly targeted towards high-value products (low dose API), orphan drugs and new chemical entities, and particularly suited for challenging recipes that require two-stage blending or more dispersive blending, the systems can be equipped with cleaning and containment features to handle highly potent formulations.

Standard Configuration

  • Up to 6 loss-in-weight feeders with automatic top-up systems

  • 2 linear blenders

  • GEA compression system

Available Options

  • PAT tools

  • Hot swap parts for fast changeover

  • Material handling system including containment features

  • Containment upgrade

  • Coater

Main Benefits

  • Reduced risk of segregation – no material hold-ups

  • Highest possible blend homogeneity – all powder particles go through the same mixing event

  • Higher material yield

  • High flexibility from very low to very high API content

  • In process blend uniformity control – second-by-second

  • Adaption to variable throughput capacities

  • No hold-up issues

  • Wider drug load range than batch processing

  • System automatically adapts to changes in bulk density

  • Adaptable top-up sizes to ensure accurate feeding

  • Automatically adjustable dwell time

  • Flexible batch size

  • Smaller footprint

Read more about how GEA and its partners are implementing this technology to lead the way toward smaller, more flexible, continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing.

Downloads

GEA 洞察

定制挤奶设备支持奶牛和农场主的福祉

健康快乐的奶牛是成功和可持续牛奶生产的关键。因此,保持奶牛健康是每个奶农努力的核心。奶牛的健康受到许多因素影响,例如根据奶牛个体需求进行适当喂养、良好的饲养条件以及新鲜的空气、水和光照。而且,挤奶方式对奶牛的健康状况也有很大的影响。GEA 因其“优质挤奶理念”而闻名,不断致力于进一步发展,并在动物健康和牛奶质量方面取得更好的成果。

利用 GEA 的整体工程解决方案实现净零排放

各行各业都在努力实现净零排放目标,同时遵守严格的脱碳法规和立法。与此同时,公司必须平衡日益增长的质量、产品开发和工艺优化需求,此外,还必须努力提高盈利能力。应对这一挑战需要采取 GEA 提供的协作和整体方法。

在餐桌上享用…新食品:打造我们食品的未来

咖啡、可可、牛奶、肉类、鱼类和蛋类 - 这些日常主食在很大程度上依赖集约农业。随着新食品技术的兴起,我们有了更多可持续的替代品。我们采访了 GEA 液体、发酵和灌装部门的高级副总裁 Reimar Gutte 博士,探讨其中的可能性和政策。

接收 GEA 新闻

订阅 GEA 的新闻,掌握 GEA 的创新信息和故事。

联系我们

我们随时为您提供帮助!您只需提供少量详细信息,我们就能回复您的查询。